News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Micrus Endovascular Corporation (MEND) and Genesis Medical Interventional, Inc. Sign License, Development and Commercialization Agreement


1/17/2008 8:57:56 AM

SAN JOSE & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) and privately held Genesis Medical Interventional, Inc. today announced that they have entered into an agreement granting Micrus the rights to Genesis’ F.A.S.T.™ Funnel Catheter™ and clot retrieval system for the treatment of ischemic stroke. The transaction includes an initial upfront payment, future development milestone payments and an undisclosed royalty on potential future products sales.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES